Immune-related pathways including HLA-DRB1∗13:02 are associated with panic disorder

[1]  N. Kamatani,et al.  High-accuracy imputation for HLA class I and II genes based on high-resolution SNP data of population-specific references , 2015, The Pharmacogenomics Journal.

[2]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[3]  K. Lavoie,et al.  Prospective Impact of Panic Disorder and Panic-Anxiety on Asthma Control, Health Service Use, and Quality of Life in Adult Patients With Asthma Over a 4-Year Follow-Up , 2014, Psychosomatic medicine.

[4]  J. Holoshitz.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by. , 2013, Discovery medicine.

[5]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[6]  M. Leboyer,et al.  The HLA-G low expressor genotype is associated with protection against bipolar disorder. , 2013, Human Immunology.

[7]  E. Shimizu,et al.  Meta-analysis of genome-wide association studies for panic disorder in the Japanese population , 2012, Translational Psychiatry.

[8]  F. McMahon,et al.  Replication and meta-analysis of TMEM132D gene variants in panic disorder , 2012, Translational Psychiatry.

[9]  Danielle L. Pfaff,et al.  Anxiety Disorder Comorbidity in Bipolar Disorder, Schizophrenia and Schizoaffective Disorder , 2012, Psychopathology.

[10]  Jason H. Moore,et al.  Pathway analysis of genomic data: concepts, methods, and prospects for future development. , 2012, Trends in genetics : TIG.

[11]  T. C. Figueiredo,et al.  Reconsidering the Association Between the Major Histocompatibility Complex and Bipolar Disorder , 2012, Journal of Molecular Neuroscience.

[12]  S. Cichon,et al.  TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies , 2011, Molecular Psychiatry.

[13]  Suhua Chang,et al.  ICSNPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical framework , 2011, Nucleic Acids Res..

[14]  E. Kang,et al.  The Genetic Basis of Panic Disorder , 2011, Journal of Korean medical science.

[15]  H. Hakonarson,et al.  Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.

[16]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[17]  Suhua Chang,et al.  i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study , 2010, Nucleic Acids Res..

[18]  K. Tokunaga,et al.  Replication of a genome-wide association study of panic disorder in a Japanese population , 2010, Journal of Human Genetics.

[19]  J. Sareen,et al.  Asthma and mental disorders in Canada: impact on functional impairment and mental health service use. , 2010, Journal of psychosomatic research.

[20]  C. Shatz,et al.  MHC Class I: An Unexpected Role in Neuronal Plasticity , 2009, Neuron.

[21]  L. Boulanger,et al.  Immune Proteins in Brain Development and Synaptic Plasticity , 2009, Neuron.

[22]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[23]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[24]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[25]  L. Criswell,et al.  Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[26]  S. Buyske,et al.  HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. , 2009, Archives of pediatrics & adolescent medicine.

[27]  I. Kanazawa,et al.  Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. , 2009, Genomics.

[28]  K. Tokunaga,et al.  Genome-wide association study of panic disorder in the Japanese population , 2009, Journal of Human Genetics.

[29]  S. Stohlman,et al.  Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis , 2007, Glia.

[30]  Fabio Macciardi,et al.  Association of the Val158Met Catechol O-Methyltransferase Genetic Polymorphism with Panic Disorder , 2006, Neuropsychopharmacology.

[31]  C. Lemière,et al.  Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients? , 2005, Respiratory medicine.

[32]  E. Maron,et al.  Associations between serotonin-related gene polymorphisms and panic disorder. , 2005, The international journal of neuropsychopharmacology.

[33]  Joo-Eon Park,et al.  Lymphocyte Subsets and Mood States in Panic Disorder Patients , 2005, Journal of Korean medical science.

[34]  J. Kennedy,et al.  Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany , 2004, Neuroscience Letters.

[35]  M. Rietschel,et al.  Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. , 2004, The international journal of neuropsychopharmacology.

[36]  Katharina Domschke,et al.  Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. , 2004, The international journal of neuropsychopharmacology.

[37]  Susan E Hodge,et al.  Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder , 2004, Neuropsychopharmacology.

[38]  H. Yoneda,et al.  Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene , 2003, Psychiatry Research.

[39]  E. Hattori,et al.  Transcriptional activities of cholecystokinin promoter haplotypes and their relevance to panic disorder susceptibility , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[40]  D. Hinton,et al.  Perforin-Mediated Effector Function Within the Central Nervous System Requires IFN-γ-Mediated MHC Up-Regulation1 , 2003, The Journal of Immunology.

[41]  S. Schleifer,et al.  Panic disorder and immunity: Few effects on circulating lymphocytes, mitogen response, and NK cell activity , 2002, Brain, Behavior, and Immunity.

[42]  B. Yu,et al.  Catechol O-methyltransferase genetic polymorphism in panic disorder. , 2002, The American journal of psychiatry.

[43]  Adele Cutler,et al.  The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. , 2002, Human immunology.

[44]  S. McElroy,et al.  The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. , 2002, Journal of affective disorders.

[45]  E. Hattori,et al.  Association studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects. , 2001, American journal of medical genetics.

[46]  M C Neale,et al.  A review and meta-analysis of the genetic epidemiology of anxiety disorders. , 2001, The American journal of psychiatry.

[47]  C. Navarrete,et al.  The HLA system in blood transfusion. , 2000, Bailliere's best practice & research. Clinical haematology.

[48]  Steven P. Hamilton,et al.  Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22 , 2000, Biological Psychiatry.

[49]  M. Nöthen,et al.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. , 1999, Human molecular genetics.

[50]  R. Noyes,et al.  Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. , 1998, American journal of medical genetics.

[51]  M. Rapaport.  Circulating Lymphocyte Phenotypic Surface Markers in Anxiety Disorder Patients and Normal Volunteers , 1998, Biological Psychiatry.

[52]  L. Bellodi,et al.  Asthma and panic attacks , 1997, Biological Psychiatry.

[53]  F. McMahon,et al.  Panic disorder with familial bipolar disorder , 1997, Biological Psychiatry.

[54]  M. Weissman,et al.  Familial aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic disorder. , 1997, Archives of general psychiatry.

[55]  S. Valverde,et al.  Psychoimmunoendocrine aspects of panic disorder , 1995 .

[56]  R. Kessler,et al.  Panic and panic disorder in the United States. , 1994, The American journal of psychiatry.

[57]  H. Akiskal,et al.  Immune cell imbalance in major depressive and panic disorders. , 1992, Neuropsychobiology.

[58]  D. Pauls,et al.  A family study of panic disorder. , 1983, Archives of general psychiatry.

[59]  A. Hasnat,et al.  Immunoglobulin levels in panic disorder patients. , 2012, Pakistan journal of pharmaceutical sciences.

[60]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[61]  T. Sasazuki,et al.  Haplotype study on C4 polymorphism in Japanese. Associations with MIHC Alleles, complotypes, and HLA-complement haplotypes , 2004, Immunogenetics.

[62]  C. Pingree,et al.  Possible association of the exetended MHC haplotype B44-SC30-DR4 with autism , 2004, Immunogenetics.

[63]  J. Potash,et al.  Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. , 2002, The American journal of psychiatry.

[64]  J. Rosenbaum,et al.  Cell‐surface expression of L‐selectin (CD62L) by blood lymphocytes: Correlates with affective parameters and severity of panic disorder , 2000, Depression and anxiety.

[65]  M. Nöthen,et al.  Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease , 1998, Molecular Psychiatry.